12,303 Shares in Astrana Health, Inc. (NASDAQ:ASTH) Purchased by Amalgamated Bank

Amalgamated Bank purchased a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) during the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 12,303 shares of the company's stock, valued at approximately $713,000.

Several other institutional investors and hedge funds also recently modified their holdings of ASTH. GAMMA Investing LLC acquired a new stake in Astrana Health in the 3rd quarter valued at $34,000. Nisa Investment Advisors LLC acquired a new stake in shares of Astrana Health in the third quarter valued at about $35,000. Central Pacific Bank Trust Division acquired a new stake in shares of Astrana Health in the third quarter valued at about $160,000. Everence Capital Management Inc. bought a new stake in Astrana Health during the third quarter worth about $272,000. Finally, Granite Bay Wealth Management LLC acquired a new position in Astrana Health during the third quarter valued at approximately $290,000. 52.77% of the stock is owned by institutional investors and hedge funds.

Astrana Health Stock Performance

Shares of NASDAQ ASTH traded down $1.09 during mid-day trading on Friday, reaching $40.81. 392,557 shares of the company were exchanged, compared to its average volume of 207,694. The stock has a market capitalization of $2.30 billion, a P/E ratio of 31.39, a P/E/G ratio of 1.96 and a beta of 1.24. The company has a quick ratio of 1.84, a current ratio of 1.91 and a debt-to-equity ratio of 0.60. The company's 50-day simple moving average is $55.04 and its 200-day simple moving average is $47.66. Astrana Health, Inc. has a twelve month low of $32.04 and a twelve month high of $63.20.

Astrana Health (NASDAQ:ASTH - Get Free Report) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.33 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The firm had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. During the same period last year, the business posted $0.47 earnings per share. As a group, research analysts predict that Astrana Health, Inc. will post 1.16 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ASTH. KeyCorp assumed coverage on Astrana Health in a research report on Friday, October 11th. They set a "sector weight" rating on the stock. Robert W. Baird boosted their target price on shares of Astrana Health from $67.00 to $86.00 and gave the stock an "outperform" rating in a report on Wednesday. Stifel Nicolaus increased their price target on shares of Astrana Health from $48.00 to $60.00 and gave the company a "buy" rating in a research note on Thursday, August 1st. BTIG Research boosted their price objective on shares of Astrana Health from $60.00 to $70.00 and gave the stock a "buy" rating in a research note on Thursday, October 3rd. Finally, TD Cowen began coverage on shares of Astrana Health in a report on Monday, October 14th. They issued a "buy" rating and a $66.00 target price on the stock. One analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of $65.17.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.